April 10, 2026Diabetes Obesity and Metabolism3 citations
Real‐World Clinical Evidence of Tirzepatide for Metabolic Abnormalities in Subjects With Type 2 Diabetes: The Multicenter Retrospective Observational Hokkaido‐ TZP Study
The aim is to evaluate the effectiveness and safety of tirzepatide in managing metabolic abnormalities associated with type 2 diabetes.
Conducted a multicenter retrospective observational analysis.
Included subjects with type 2 diabetes receiving tirzepatide.
Assessed clinical outcomes related to metabolic abnormalities.
Tirzepatide showed robust efficacy in improving metabolic parameters.
Safety profile was favorable regardless of prior incretin therapy.
Abstract
Tirzepatide demonstrated robust clinical efficacy and a favourable safety profile in a real-world clinical setting, regardless of whether incretin-based therapy had been administered previously.